High-Consequence Infectious Diseases, Bioterrorism, and the Imperative for International and US Biosecurity and Biosafety Frameworks for Biocontainment Clinical Laboratories
by Dr. Syra Madad (co-author) in Health Security
An Improved Alert System for Emerging Infectious Diseases
by Dr. Nahid Bhadelia in JAMA
Activation of STAT3-mediated ciliated cell survival protects against severe infection by respiratory syncytial virus
by Dr. Adam Hume (co-author) in The Journal of Clinical Investigation
Analysis of Monkeypox Virus Exposures and Lesions by Anatomic Site
by Dr. David Hamer (co-author) in Emerging Infectious Diseases
Needs Unfulfilled by Current Hepatitis B Vaccines
chapter by Dr. Patricia Hibberd (co-author) in Hepatitis B Vaccines in Clinical Practice
Antibiotic use in infants in the 6 weeks after delivery in seven low- and middle-income countries: findings from the A-PLUS trial
by Dr. Patricia Hibberd (co-author) in Paediatrics and International Child Health
Developing Training in Response to High-Consequence Infectious Diseases and Preparedness Measures for the Future
by Dr. Abigail Lowe (co-author) in Health Security
How to prepare for the next inevitable Ebola outbreak: lessons from West Africa
By Dr. Mosoka Fallah (co-author) in Nature Medicine
Access to medicines among asylum seekers, refugees and undocumented migrants across the migratory cycle in Europe: a scoping review
By Dr. Veronika Wirtz (co-author) in BMJ Global Health
Host Response Markers of Inflammation and Endothelial Activation Associated with COVID-19 Severity and Mortality: A GeoSentinel Prospective Observational Cohort
by Dr. David Hamer (co-author) in Viruses